ReviewFrontiers in public health2022
Multiple Factors Causing Myopia and the Possible Treatments: A Mini Review.
Review in Frontiers in public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Orthokeratology in controlling myopia of children: a meta-analysis of randomized controlled trials.BMC ophthalmology · 2023Pooled it
- Photobiology in ophthalmology: from evolutionary adaptation to translational therapeutics.Japanese journal of ophthalmology · 2026Review
- Pyroptosis-associated inflammasome activation contributes to scleral remodeling in experimental myopia.International journal of ophthalmology · 2026Article
- Cross-sectional study of myopia prevalence and associated risk factors among children and adolescents in Shaanxi Province, China, in 2021.Annals of medicine · 2025Article
- Inflammation and Immune Pathways in Myopia: An Overview on Pathomechanisms and Treatment Prospects.Clinical reviews in allergy & immunology · 2025Review
- Mechanism of electroacupuncture involve in lens-induced myopia guinea pigs by inhibiting wnt/β-catenin signaling pathway.Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan · 2025Article
- Dose-dependent myopia-suppressing effect of 4-phenlybutyric acid eye drops in a mouse myopia model under masked condition.BMC ophthalmology · 2025Article
- Femtosecond laser small incision lenticule extraction on binocularity for myopia with glasses-free 3D technique.International journal of ophthalmology · 2025Article
- Refractive status and histological changes after posterior scleral reinforcement in guinea pig.International journal of ophthalmology · 2025Article
- Myopia control efficacy of peripheral defocus modifying spectacle lenses in children and adolescents: a Meta-analysis.International journal of ophthalmology · 2025Article
- Retinal features as predictive indicators for high myopia: insights from explainable multi-machine learning models.Frontiers in bioengineering and biotechnology · 2025Article
- Behavioural determinants of physiologically-relevant light exposure.Communications psychology · 2024Review
- Analysis of corneal remodeling post-myopic photorefractive keratectomy with the WaveLight® EX500 excimer laser.Scientific reports · 2024Article
- Ciliary muscles contraction leads to axial length extension--The possible initiating factor for myopia.PloS one · 2024Article
- Clinical Observation of Posterior-Chamber Phakic Implantable Collamer Lens V4c Implantation in Myopic Patients with Shallow Anterior Chamber Depth: A Retrospective, Consecutive Observational Study.Journal of ophthalmology · 2024Article
- Correlation between choroidal thickness and the degree of myopia.Technology and health care : official journal of the European Society for Engineering and Medicine · 2024Article
- Retardation of myopia by atropine regimes.International journal of ophthalmology · 2024Review
- Impact of Covid-19 on Pediatric Ophthalmology Care: Lessons Learned.Pediatric health, medicine and therapeutics · 2023Review
- Complement and local ocular inflammatory response: Chronic immune factors in myopia.Science progressReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The myopia epidemic has become a global public health problem. Although myopia is progressing worldwide, the recent coronavirus infections 2019 (COVID-19) outbreak has spurred myopia progression. The current evidence-based treatments for humans are atropine eye drops, optical treatment with defocus, use of orthokeratology, extending proximity working distance, pausing from near work every half hour and increased time outside the home. Studies on myopia using animal models have been conducted for more than 40 years. In recent years, new mechanisms of myopia suppression have been revealed from animal experiments such as inflammation control, intraocular pressure control, light control, and the activity of early growth response protein 1 control. This mini-review provides a summary of the scientific evidence currently available on the control of myopia, and the possible treatments mitigating myopia.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.